Bausch Health Companies Inc. Sale Leaseback Transaction, Net Proceeds (Deprecated 2014-01-31)
Bausch Health Companies Inc. (BHC) reported Sale Leaseback Transaction, Net Proceeds (Deprecated 2014-01-31) of $5.30 million for the 9-month period ending 2009-09-30, per its 10-Q filed 2010-11-05.
Discontinued › Notes › Leases
us-gaap:SaleLeasebackTransactionNetProceeds · last filed 2010-11-05
- Bausch Health Companies Inc. sale leaseback transaction, net proceeds (deprecated 2014-01-31) for the quarter ending 2009-09-30 was $0.00.
- Bausch Health Companies Inc. sale leaseback transaction, net proceeds (deprecated 2014-01-31) for the quarter ending 2009-06-30 was $5.30M.
| Period end | Sale Leaseback Transaction, Net Proceeds (Deprecated 2014-01-31) 3 month | Sale Leaseback Transaction, Net Proceeds (Deprecated 2014-01-31) 6 month | Sale Leaseback Transaction, Net Proceeds (Deprecated 2014-01-31) 9 month |
|---|---|---|---|
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $5.30M derived: sum of 2 quarters · filed 2010-11-05 | $5.30M 10-Q · filed 2010-11-05 |
| 2009-06-30 | $5.30M 10-Q · filed 2010-08-06 | $5.30M 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |